Skip to main content
Erschienen in: Journal of Gastrointestinal Surgery 5/2017

12.01.2017 | Original Article

Kinetic Changes in Liver Parenchyma After Preoperative Chemotherapy for Patients with Colorectal Liver Metastases

verfasst von: Keigo Tani, Junichi Shindoh, Takeshi Takamoto, Junji Shibahara, Yujiro Nishioka, Takuya Hashimoto, Yoshihiro Sakamoto, Kiyoshi Hasegawa, Masatoshi Makuuchi, Norihiro Kokudo

Erschienen in: Journal of Gastrointestinal Surgery | Ausgabe 5/2017

Einloggen, um Zugang zu erhalten

Abstract

Background

Total liver volume (TLV) empirically changes after aggressive preoperative chemotherapy for colorectal liver metastases (CLM). However, the actual degree of changes in normal liver parenchyma and its clinical relevance remain unclear.

Methods

Morphometric data of 110 patients who underwent initial hepatectomy after preoperative chemotherapy were reviewed. TLVs before and after chemotherapy were measured using a computer-based volumetry software and their relevance to clinical factors was investigated.

Results

More than 10% of decrease in TLV was observed in 42 (38.2%) patients, and more than 10% of increase was observed in 11 (10.0%) patients. Change in TLV was within 10% in the remaining 57 (51.8%) patients. Indocyanine green retention rate at 15 min (ICG-R15) value was significantly higher in patients with TLV decrease more than 10% (13.4 vs. 9.3 vs. 8.5%; p = 0.004). Steatosis in the underlying liver was significantly frequent in patients with TLV increase more than 10% (p < 0.001). Multivariate logistic regression analysis revealed that more than 10% of shrinkage in TLV after chemotherapy was independently associated with ICG-R15 >15% (odds ratio 8.8; p = 0.0001). Tendency of correlation was confirmed in the kinetic changes in TLV and ICG-R15 during chemotherapy even though there was no statistical significance (r = −0.33, p = 0.080).

Conclusion

Perichemotherapy kinetic changes in TLV may predict histopathologic changes or changes in hepatic functional reserve in the underlying liver. More than 10% of shrinkage in TLV is associated with impaired hepatic functional reserve, and it can be a new supplemental finding in the prediction of surgical risk of major hepatectomy for CLM.
Literatur
1.
Zurück zum Zitat Adam R, de Gramont A, Figueras J, Kokudo N, Kunstlinger F, Loyer E, Poston G, Rougier P, Rubbia-Brandt L, Sobrero A, Teh C, Tejpar S, Van Cutsem E, Vauthey JN, Pahlman L, of the Eg: Managing synchronous liver metastases from colorectal cancer: a multidisciplinary international consensus. Cancer Treat Rev 2015;41:729-741. Adam R, de Gramont A, Figueras J, Kokudo N, Kunstlinger F, Loyer E, Poston G, Rougier P, Rubbia-Brandt L, Sobrero A, Teh C, Tejpar S, Van Cutsem E, Vauthey JN, Pahlman L, of the Eg: Managing synchronous liver metastases from colorectal cancer: a multidisciplinary international consensus. Cancer Treat Rev 2015;41:729-741.
2.
Zurück zum Zitat Kopetz S, Chang GJ, Overman MJ, Eng C, Sargent DJ, Larson DW, Grothey A, Vauthey JN, Nagorney DM, McWilliams RR: Improved survival in metastatic colorectal cancer is associated with adoption of hepatic resection and improved chemotherapy. Journal of clinical oncology: official journal of the American Society of Clinical Oncology 2009;27:3677-3683.CrossRef Kopetz S, Chang GJ, Overman MJ, Eng C, Sargent DJ, Larson DW, Grothey A, Vauthey JN, Nagorney DM, McWilliams RR: Improved survival in metastatic colorectal cancer is associated with adoption of hepatic resection and improved chemotherapy. Journal of clinical oncology: official journal of the American Society of Clinical Oncology 2009;27:3677-3683.CrossRef
3.
Zurück zum Zitat Folprecht G, Gruenberger T, Bechstein WO, Raab HR, Lordick F, Hartmann JT, Lang H, Frilling A, Stoehlmacher J, Weitz J, Konopke R, Stroszczynski C, Liersch T, Ockert D, Herrmann T, Goekkurt E, Parisi F, Kohne CH: Tumour response and secondary resectability of colorectal liver metastases following neoadjuvant chemotherapy with cetuximab: the CELIM randomised phase 2 trial. The Lancet Oncology 2010;11:38-47.CrossRefPubMed Folprecht G, Gruenberger T, Bechstein WO, Raab HR, Lordick F, Hartmann JT, Lang H, Frilling A, Stoehlmacher J, Weitz J, Konopke R, Stroszczynski C, Liersch T, Ockert D, Herrmann T, Goekkurt E, Parisi F, Kohne CH: Tumour response and secondary resectability of colorectal liver metastases following neoadjuvant chemotherapy with cetuximab: the CELIM randomised phase 2 trial. The Lancet Oncology 2010;11:38-47.CrossRefPubMed
4.
Zurück zum Zitat Folprecht G, Grothey A, Alberts S, Raab HR, Kohne CH: Neoadjuvant treatment of unresectable colorectal liver metastases: correlation between tumour response and resection rates. Annals of oncology: official journal of the European Society for Medical Oncology / ESMO 2005;16:1311-1319.CrossRef Folprecht G, Grothey A, Alberts S, Raab HR, Kohne CH: Neoadjuvant treatment of unresectable colorectal liver metastases: correlation between tumour response and resection rates. Annals of oncology: official journal of the European Society for Medical Oncology / ESMO 2005;16:1311-1319.CrossRef
5.
Zurück zum Zitat Aloia T, Sebagh M, Plasse M, Karam V, Levi F, Giacchetti S, Azoulay D, Bismuth H, Castaing D, Adam R: Liver histology and surgical outcomes after preoperative chemotherapy with fluorouracil plus oxaliplatin in colorectal cancer liver metastases. Journal of clinical oncology: official journal of the American Society of Clinical Oncology 2006;24:4983-4990.CrossRef Aloia T, Sebagh M, Plasse M, Karam V, Levi F, Giacchetti S, Azoulay D, Bismuth H, Castaing D, Adam R: Liver histology and surgical outcomes after preoperative chemotherapy with fluorouracil plus oxaliplatin in colorectal cancer liver metastases. Journal of clinical oncology: official journal of the American Society of Clinical Oncology 2006;24:4983-4990.CrossRef
6.
Zurück zum Zitat Narita M, Oussoultzoglou E, Fuchshuber P, Pessaux P, Chenard MP, Rosso E, Nobili C, Jaeck D, Bachellier P: What is a safe future liver remnant size in patients undergoing major hepatectomy for colorectal liver metastases and treated by intensive preoperative chemotherapy? Ann Surg Oncol 2012;19:2526-2538.CrossRefPubMed Narita M, Oussoultzoglou E, Fuchshuber P, Pessaux P, Chenard MP, Rosso E, Nobili C, Jaeck D, Bachellier P: What is a safe future liver remnant size in patients undergoing major hepatectomy for colorectal liver metastases and treated by intensive preoperative chemotherapy? Ann Surg Oncol 2012;19:2526-2538.CrossRefPubMed
7.
Zurück zum Zitat Shindoh J, Tzeng CW, Aloia TA, Curley SA, Zimmitti G, Wei SH, Huang SY, Mahvash A, Gupta S, Wallace MJ, Vauthey JN: Optimal future liver remnant in patients treated with extensive preoperative chemotherapy for colorectal liver metastases. Ann Surg Oncol 2013;20:2493-2500.CrossRefPubMed Shindoh J, Tzeng CW, Aloia TA, Curley SA, Zimmitti G, Wei SH, Huang SY, Mahvash A, Gupta S, Wallace MJ, Vauthey JN: Optimal future liver remnant in patients treated with extensive preoperative chemotherapy for colorectal liver metastases. Ann Surg Oncol 2013;20:2493-2500.CrossRefPubMed
8.
Zurück zum Zitat Takamoto T, Hashimoto T, Sano K, Maruyama Y, Inoue K, Ogata S, Takemura T, Kokudo N, Makuuchi M: Recovery of liver function after the cessation of preoperative chemotherapy for colorectal liver metastasis. Annals of surgical oncology 2010;17:2747-2755.CrossRefPubMed Takamoto T, Hashimoto T, Sano K, Maruyama Y, Inoue K, Ogata S, Takemura T, Kokudo N, Makuuchi M: Recovery of liver function after the cessation of preoperative chemotherapy for colorectal liver metastasis. Annals of surgical oncology 2010;17:2747-2755.CrossRefPubMed
9.
Zurück zum Zitat Vauthey JN, Pawlik TM, Ribero D, Wu TT, Zorzi D, Hoff PM, Xiong HQ, Eng C, Lauwers GY, Mino-Kenudson M, Risio M, Muratore A, Capussotti L, Curley SA, Abdalla EK: Chemotherapy regimen predicts steatohepatitis and an increase in 90-day mortality after surgery for hepatic colorectal metastases. J Clin Oncol 2006;24:2065-2072.CrossRefPubMed Vauthey JN, Pawlik TM, Ribero D, Wu TT, Zorzi D, Hoff PM, Xiong HQ, Eng C, Lauwers GY, Mino-Kenudson M, Risio M, Muratore A, Capussotti L, Curley SA, Abdalla EK: Chemotherapy regimen predicts steatohepatitis and an increase in 90-day mortality after surgery for hepatic colorectal metastases. J Clin Oncol 2006;24:2065-2072.CrossRefPubMed
10.
Zurück zum Zitat Seyama Y, Kokudo N: Assessment of liver function for safe hepatic resection. Hepatology research: the official journal of the Japan Society of Hepatology 2009;39:107-116.CrossRef Seyama Y, Kokudo N: Assessment of liver function for safe hepatic resection. Hepatology research: the official journal of the Japan Society of Hepatology 2009;39:107-116.CrossRef
11.
Zurück zum Zitat Makuuchi M, Kosuge T, Takayama T, Yamazaki S, Kakazu T, Miyagawa S, Kawasaki S: Surgery for small liver cancers. Semin Surg Oncol 1993;9:298-304.CrossRefPubMed Makuuchi M, Kosuge T, Takayama T, Yamazaki S, Kakazu T, Miyagawa S, Kawasaki S: Surgery for small liver cancers. Semin Surg Oncol 1993;9:298-304.CrossRefPubMed
12.
Zurück zum Zitat Urata K, Kawasaki S, Matsunami H, Hashikura Y, Ikegami T, Ishizone S, Momose Y, Komiyama A, Makuuchi M: Calculation of child and adult standard liver volume for liver transplantation. Hepatology (Baltimore, Md) 1995;21:1317-1321.CrossRef Urata K, Kawasaki S, Matsunami H, Hashikura Y, Ikegami T, Ishizone S, Momose Y, Komiyama A, Makuuchi M: Calculation of child and adult standard liver volume for liver transplantation. Hepatology (Baltimore, Md) 1995;21:1317-1321.CrossRef
13.
Zurück zum Zitat Dindo D, Demartines N, Clavien PA: Classification of surgical complications: a new proposal with evaluation in a cohort of 6336 patients and results of a survey. Annals of surgery 2004;240:205-213.CrossRefPubMedPubMedCentral Dindo D, Demartines N, Clavien PA: Classification of surgical complications: a new proposal with evaluation in a cohort of 6336 patients and results of a survey. Annals of surgery 2004;240:205-213.CrossRefPubMedPubMedCentral
14.
Zurück zum Zitat Mullen JT, Ribero D, Reddy SK, Donadon M, Zorzi D, Gautam S, Abdalla EK, Curley SA, Capussotti L, Clary BM, Vauthey JN: Hepatic insufficiency and mortality in 1,059 noncirrhotic patients undergoing major hepatectomy. Journal of the American College of Surgeons 2007;204:854-862; discussion 862-854.CrossRefPubMed Mullen JT, Ribero D, Reddy SK, Donadon M, Zorzi D, Gautam S, Abdalla EK, Curley SA, Capussotti L, Clary BM, Vauthey JN: Hepatic insufficiency and mortality in 1,059 noncirrhotic patients undergoing major hepatectomy. Journal of the American College of Surgeons 2007;204:854-862; discussion 862-854.CrossRefPubMed
15.
Zurück zum Zitat Kleiner DE, Brunt EM, Van Natta M, Behling C, Contos MJ, Cummings OW, Ferrell LD, Liu YC, Torbenson MS, Unalp-Arida A, Yeh M, McCullough AJ, Sanyal AJ, Nonalcoholic Steatohepatitis Clinical Research N: Design and validation of a histological scoring system for nonalcoholic fatty liver disease. Hepatology (Baltimore, Md) 2005;41:1313-1321.CrossRef Kleiner DE, Brunt EM, Van Natta M, Behling C, Contos MJ, Cummings OW, Ferrell LD, Liu YC, Torbenson MS, Unalp-Arida A, Yeh M, McCullough AJ, Sanyal AJ, Nonalcoholic Steatohepatitis Clinical Research N: Design and validation of a histological scoring system for nonalcoholic fatty liver disease. Hepatology (Baltimore, Md) 2005;41:1313-1321.CrossRef
16.
Zurück zum Zitat Rubbia-Brandt L, Audard V, Sartoretti P, Roth AD, Brezault C, Le Charpentier M, Dousset B, Morel P, Soubrane O, Chaussade S, Mentha G, Terris B: Severe hepatic sinusoidal obstruction associated with oxaliplatin-based chemotherapy in patients with metastatic colorectal cancer. Annals of oncology: official journal of the European Society for Medical Oncology / ESMO 2004;15:460-466.CrossRef Rubbia-Brandt L, Audard V, Sartoretti P, Roth AD, Brezault C, Le Charpentier M, Dousset B, Morel P, Soubrane O, Chaussade S, Mentha G, Terris B: Severe hepatic sinusoidal obstruction associated with oxaliplatin-based chemotherapy in patients with metastatic colorectal cancer. Annals of oncology: official journal of the European Society for Medical Oncology / ESMO 2004;15:460-466.CrossRef
17.
Zurück zum Zitat Chun YS, Laurent A, Maru D, Vauthey JN: Management of chemotherapy-associated hepatotoxicity in colorectal liver metastases. The Lancet Oncology 2009;10:278-286.CrossRefPubMed Chun YS, Laurent A, Maru D, Vauthey JN: Management of chemotherapy-associated hepatotoxicity in colorectal liver metastases. The Lancet Oncology 2009;10:278-286.CrossRefPubMed
18.
Zurück zum Zitat Cleary JM, Tanabe KT, Lauwers GY, Zhu AX: Hepatic toxicities associated with the use of preoperative systemic therapy in patients with metastatic colorectal adenocarcinoma to the liver. The oncologist 2009;14:1095-1105.CrossRefPubMed Cleary JM, Tanabe KT, Lauwers GY, Zhu AX: Hepatic toxicities associated with the use of preoperative systemic therapy in patients with metastatic colorectal adenocarcinoma to the liver. The oncologist 2009;14:1095-1105.CrossRefPubMed
19.
Zurück zum Zitat Kemeny N: Presurgical chemotherapy in patients being considered for liver resection. The oncologist 2007;12:825-839.CrossRefPubMed Kemeny N: Presurgical chemotherapy in patients being considered for liver resection. The oncologist 2007;12:825-839.CrossRefPubMed
20.
Zurück zum Zitat Krieger PM, Tamandl D, Herberger B, Faybik P, Fleischmann E, Maresch J, Gruenberger T: Evaluation of chemotherapy-associated liver injury in patients with colorectal cancer liver metastases using indocyanine green clearance testing. Annals of surgical oncology 2011;18:1644-1650.CrossRefPubMed Krieger PM, Tamandl D, Herberger B, Faybik P, Fleischmann E, Maresch J, Gruenberger T: Evaluation of chemotherapy-associated liver injury in patients with colorectal cancer liver metastases using indocyanine green clearance testing. Annals of surgical oncology 2011;18:1644-1650.CrossRefPubMed
21.
Zurück zum Zitat Narita M, Oussoultzoglou E, Chenard MP, Fuchshuber P, Rather M, Rosso E, Addeo P, Jaeck D, Bachellier P: Liver injury due to chemotherapy-induced sinusoidal obstruction syndrome is associated with sinusoidal capillarization. Annals of surgical oncology 2012;19:2230-2237.CrossRefPubMed Narita M, Oussoultzoglou E, Chenard MP, Fuchshuber P, Rather M, Rosso E, Addeo P, Jaeck D, Bachellier P: Liver injury due to chemotherapy-induced sinusoidal obstruction syndrome is associated with sinusoidal capillarization. Annals of surgical oncology 2012;19:2230-2237.CrossRefPubMed
22.
Zurück zum Zitat Wakiya T, Kudo D, Toyoki Y, Ishido K, Kimura N, Narumi S, Kijima H, Hakamada K: Evaluation of the usefulness of the indocyanine green clearance test for chemotherapy-associated liver injury in patients with colorectal cancer liver metastasis. Annals of surgical oncology 2014;21:167-172.CrossRefPubMed Wakiya T, Kudo D, Toyoki Y, Ishido K, Kimura N, Narumi S, Kijima H, Hakamada K: Evaluation of the usefulness of the indocyanine green clearance test for chemotherapy-associated liver injury in patients with colorectal cancer liver metastasis. Annals of surgical oncology 2014;21:167-172.CrossRefPubMed
23.
Zurück zum Zitat Imamura Y, Uto H, Hiramine Y, Hosoyamada K, Ijuin S, Yoshifuku S, Miyahara H, Maenohara S, Oketani M, Ido A, Tsubouchi H: Increasing prevalence of diabetes mellitus in association with fatty liver in a Japanese population. Journal of gastroenterology 2014;49:1406-1413.CrossRefPubMed Imamura Y, Uto H, Hiramine Y, Hosoyamada K, Ijuin S, Yoshifuku S, Miyahara H, Maenohara S, Oketani M, Ido A, Tsubouchi H: Increasing prevalence of diabetes mellitus in association with fatty liver in a Japanese population. Journal of gastroenterology 2014;49:1406-1413.CrossRefPubMed
24.
Zurück zum Zitat Nosher JL, Ohman-Strickland PA, Jabbour S, Narra V, Nosher B: Changes in liver and spleen volumes and liver function after radioembolization with yttrium-90 resin microspheres. Journal of vascular and interventional radiology: JVIR 2011;22:1706-1713.CrossRefPubMed Nosher JL, Ohman-Strickland PA, Jabbour S, Narra V, Nosher B: Changes in liver and spleen volumes and liver function after radioembolization with yttrium-90 resin microspheres. Journal of vascular and interventional radiology: JVIR 2011;22:1706-1713.CrossRefPubMed
Metadaten
Titel
Kinetic Changes in Liver Parenchyma After Preoperative Chemotherapy for Patients with Colorectal Liver Metastases
verfasst von
Keigo Tani
Junichi Shindoh
Takeshi Takamoto
Junji Shibahara
Yujiro Nishioka
Takuya Hashimoto
Yoshihiro Sakamoto
Kiyoshi Hasegawa
Masatoshi Makuuchi
Norihiro Kokudo
Publikationsdatum
12.01.2017
Verlag
Springer US
Erschienen in
Journal of Gastrointestinal Surgery / Ausgabe 5/2017
Print ISSN: 1091-255X
Elektronische ISSN: 1873-4626
DOI
https://doi.org/10.1007/s11605-017-3359-4

Weitere Artikel der Ausgabe 5/2017

Journal of Gastrointestinal Surgery 5/2017 Zur Ausgabe

Update Chirurgie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

S3-Leitlinie „Diagnostik und Therapie des Karpaltunnelsyndroms“

Karpaltunnelsyndrom BDC Leitlinien Webinare
CME: 2 Punkte

Das Karpaltunnelsyndrom ist die häufigste Kompressionsneuropathie peripherer Nerven. Obwohl die Anamnese mit dem nächtlichen Einschlafen der Hand (Brachialgia parästhetica nocturna) sehr typisch ist, ist eine klinisch-neurologische Untersuchung und Elektroneurografie in manchen Fällen auch eine Neurosonografie erforderlich. Im Anfangsstadium sind konservative Maßnahmen (Handgelenksschiene, Ergotherapie) empfehlenswert. Bei nicht Ansprechen der konservativen Therapie oder Auftreten von neurologischen Ausfällen ist eine Dekompression des N. medianus am Karpaltunnel indiziert.

Prof. Dr. med. Gregor Antoniadis
Berufsverband der Deutschen Chirurgie e.V.

S2e-Leitlinie „Distale Radiusfraktur“

Radiusfraktur BDC Leitlinien Webinare
CME: 2 Punkte

Das Webinar beschäftigt sich mit Fragen und Antworten zu Diagnostik und Klassifikation sowie Möglichkeiten des Ausschlusses von Zusatzverletzungen. Die Referenten erläutern, welche Frakturen konservativ behandelt werden können und wie. Das Webinar beantwortet die Frage nach aktuellen operativen Therapiekonzepten: Welcher Zugang, welches Osteosynthesematerial? Auf was muss bei der Nachbehandlung der distalen Radiusfraktur geachtet werden?

PD Dr. med. Oliver Pieske
Dr. med. Benjamin Meyknecht
Berufsverband der Deutschen Chirurgie e.V.

S1-Leitlinie „Empfehlungen zur Therapie der akuten Appendizitis bei Erwachsenen“

Appendizitis BDC Leitlinien Webinare
CME: 2 Punkte

Inhalte des Webinars zur S1-Leitlinie „Empfehlungen zur Therapie der akuten Appendizitis bei Erwachsenen“ sind die Darstellung des Projektes und des Erstellungswegs zur S1-Leitlinie, die Erläuterung der klinischen Relevanz der Klassifikation EAES 2015, die wissenschaftliche Begründung der wichtigsten Empfehlungen und die Darstellung stadiengerechter Therapieoptionen.

Dr. med. Mihailo Andric
Berufsverband der Deutschen Chirurgie e.V.